NCT01253226 A Study for Japanese Participants With Rheumatoid Arthritis (RA) Status COMPLETED Phase PHASE1
NCT01251120 A Study of RoActemra/Actemra (Tocilizumab) in Combination With DMARDs Versus Current Best Practice DMARD Therapy in Patients With Rheumatoid Arthritis Status TERMINATED Phase PHASE4
NCT01250548 The Controlled Trial of Apremilast for Rheumatoid Arthritis Treatment (CARAT) Status COMPLETED Phase PHASE2
NCT01248780 Study of Subcutaneous Golimumab in Chinese Patients With Active Rheumatoid Arthritis Despite Methotrexate Therapy Status COMPLETED Phase PHASE3
NCT01245790 A Study of Fostamatinib in Subjects With Impaired Kidney Function Status COMPLETED Phase PHASE1
NCT01245452 Study of the Response and Cardiorespiratory Endurance in Early RA Patients Treated With Tocilizumab or Methotrexate Status COMPLETED Phase NA
NCT01245439 A Study of RoActemra/Actemra (Tocilizumab) in Patients With Moderate to Severe Rheumatoid Arthritis Status COMPLETED Phase PHASE3
NCT01244958 Addition of Rituximab to Leflunomide in Patients With Active Rheumatoid Arthritis Status COMPLETED Phase PHASE3
NCT01242917 A Study to Evaluate the Safety and Efficacy of CCX354-C in Subjects With Rheumatoid Arthritis Partially Responsive to Methotrexate Therapy Status COMPLETED Phase PHASE2
NCT01242514 Evaluation of Long-term Safety and Effectiveness of Fostamatinib in the Treatment of Rheumatoid Arthritis (RA) Status TERMINATED Phase PHASE3
NCT01242488 Efficacy and Safety of CDP6038 in Patients With Rheumatoid Arthritis With an Unsuccessful Response to Anti-Tumor Necrosis Factor (Anti-TNF) Therapy Status COMPLETED Phase PHASE2
NCT01235598 Magnetic Resonance Image Verified Early Response to Certolizumab Pegol in Subjects With Active Rheumatoid Arthritis (RA) Status COMPLETED Phase PHASE3
NCT01235507 A Study of RoActemra/Actemra (Tocilizumab) in Combination With Methotrexate in Patients With Active Rheumatoid Arthritis Who Have an Inadequate Response to Disease-Modifying Antirheumatic Drugs (DMARDs) (ALABASTER) Status COMPLETED Phase PHASE3
NCT01232569 A Study of RoActemra/Actemra (Tocilizumab) Given Subcutaneously in Combination With Traditional DMARDs in Patients With Moderate to Severe Active Rheumatoid Arthritis Status COMPLETED Phase PHASE3
NCT01231321 A Study of Adalimumab When Added to Inadequate Standard Anti-rheumatic Therapy in Patients With Active Rheumatoid Arthritis Status COMPLETED Phase PHASE3
NCT01228812 Physical Activity Behavior of Rheumatoid Arthritis Patients and Healthy Controls Status COMPLETED Phase N/A
NCT01225991 Milnacipran for Treatment of Pain in Older Adults With Rheumatoid Arthritis Status COMPLETED Phase PHASE4
NCT01225393 A Study to Evaluate the Efficacy and Safety of MLTA3698A in Combination With a Disease-Modifying Anti-Rheumatic Drug (DMARD) Compared With Adalimumab in Combination With a DMARD in Patients With Active Rheumatoid Arthritis Status COMPLETED Phase PHASE2